Atrial Fibrillation Clinical Trial 20203213

[LCID Study Number: 20203213]

WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation (CHAMPION-AF)

The purpose of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

Disease/Condition: Atrial Fibrillation

Department: Cardiology – Anticoagulation

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-1901

Protocol #: 20203213
Principal Investigator(s): Bruce G. Hook
Study Coordinator(s): Jean Byrne
Trial Phase: Investigator Initiated Study Category B Device